Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China.
Osteoporos Int. 2013 Mar;24(3):1127-9. doi: 10.1007/s00198-012-1979-9. Epub 2012 Apr 12.
Strontium ranelate is an effective drug that was developed for treating osteoporosis. Here, we report the case of a 62-year-old woman who developed headache and diffuse scalp hair loss 1 week after receiving strontium ranelate treatment for osteoporosis. The treatment was subsequently stopped because of the intractable headache. Nevertheless, the patient continued to lose hair for 6 weeks following treatment discontinuation. Histopathological analysis of scalp tissues revealed anagen effluvium. The patient's hair started regrowing slowly 2 months after treatment with strontium ranelate was discontinued.
雷奈酸锶是一种有效的药物,专门用于治疗骨质疏松症。在此,我们报告了一例 62 岁女性的病例,该患者在接受雷奈酸锶治疗骨质疏松症后 1 周出现头痛和弥漫性头皮脱发。由于顽固的头痛,治疗随后停止。然而,停药后患者仍继续脱发 6 周。头皮组织的组织病理学分析显示生长期脱发。雷奈酸锶治疗停止后 2 个月,患者的头发开始缓慢再生。